Cargando…
Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068888/ https://www.ncbi.nlm.nih.gov/pubmed/32164744 http://dx.doi.org/10.1186/s13058-020-01265-y |
| _version_ | 1783505664473038848 |
|---|---|
| author | Zundelevich, Adi Dadiani, Maya Kahana-Edwin, Smadar Itay, Amit Sella, Tal Gadot, Moran Cesarkas, Karen Farage-Barhom, Sarit Saar, Efrat Glick Eyal, Eran Kol, Nitzan Pavlovski, Anya Balint-Lahat, Nora Dick-Necula, Daniela Barshack, Iris Kaufman, Bella Gal-Yam, Einav Nili |
| author_facet | Zundelevich, Adi Dadiani, Maya Kahana-Edwin, Smadar Itay, Amit Sella, Tal Gadot, Moran Cesarkas, Karen Farage-Barhom, Sarit Saar, Efrat Glick Eyal, Eran Kol, Nitzan Pavlovski, Anya Balint-Lahat, Nora Dick-Necula, Daniela Barshack, Iris Kaufman, Bella Gal-Yam, Einav Nili |
| author_sort | Zundelevich, Adi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7068888 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70688882020-03-18 Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis Zundelevich, Adi Dadiani, Maya Kahana-Edwin, Smadar Itay, Amit Sella, Tal Gadot, Moran Cesarkas, Karen Farage-Barhom, Sarit Saar, Efrat Glick Eyal, Eran Kol, Nitzan Pavlovski, Anya Balint-Lahat, Nora Dick-Necula, Daniela Barshack, Iris Kaufman, Bella Gal-Yam, Einav Nili Breast Cancer Res Correction BioMed Central 2020-03-12 2020 /pmc/articles/PMC7068888/ /pubmed/32164744 http://dx.doi.org/10.1186/s13058-020-01265-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Zundelevich, Adi Dadiani, Maya Kahana-Edwin, Smadar Itay, Amit Sella, Tal Gadot, Moran Cesarkas, Karen Farage-Barhom, Sarit Saar, Efrat Glick Eyal, Eran Kol, Nitzan Pavlovski, Anya Balint-Lahat, Nora Dick-Necula, Daniela Barshack, Iris Kaufman, Bella Gal-Yam, Einav Nili Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis |
| title | Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis |
| title_full | Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis |
| title_fullStr | Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis |
| title_full_unstemmed | Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis |
| title_short | Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis |
| title_sort | correction to: esr1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068888/ https://www.ncbi.nlm.nih.gov/pubmed/32164744 http://dx.doi.org/10.1186/s13058-020-01265-y |
| work_keys_str_mv | AT zundelevichadi correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT dadianimaya correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT kahanaedwinsmadar correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT itayamit correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT sellatal correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT gadotmoran correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT cesarkaskaren correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT faragebarhomsarit correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT saarefratglick correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT eyaleran correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT kolnitzan correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT pavlovskianya correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT balintlahatnora correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT dickneculadaniela correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT barshackiris correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT kaufmanbella correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis AT galyameinavnili correctiontoesr1mutationsarefrequentinnewlydiagnosedmetastaticandlocoregionalrecurrenceofendocrinetreatedbreastcancerandcarryworseprognosis |